Aldeyra Therapeutics Inc. (ALDX) CEO Dr. Todd Brady on Q1 2022 Results - Earnings Call Transcript
Aldeyra Therapeutics Inc. (ALDX) CEO Dr. Todd Brady on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Inhibikase Therapeutics, Inc. (IKT) CEO Milton Werner on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Vivos Therapeutics, Inc. (VVOS) CEO Kirk Huntsman on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Clarus Therapeutics Holdings, Inc. (CRXT) CEO Bob Dudley on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Y-mAbs Therapeutics, Inc. (YMAB) CEO Thomas Gad on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha